Population pharmacokinetic-pharmacodynamic target attainment analysis of imipenem plasma and urine data in neonates and children.
about
Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunologyPooled population pharmacokinetic model of imipenem in plasma and the lung epithelial lining fluidEvaluation of evidence for pharmacokinetics-pharmacodynamics-based dose optimization of antimicrobials for treating Gram-negative infections in neonatesPharmacometric Approaches to Personalize Use of Primarily Renally Eliminated Antibiotics in Preterm and Term Neonates.Quantitative analysis of gentamicin exposure in neonates and infants calls into question its current dosing recommendations.
P2860
Population pharmacokinetic-pharmacodynamic target attainment analysis of imipenem plasma and urine data in neonates and children.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Population pharmacokinetic-pha ...... data in neonates and children.
@ast
Population pharmacokinetic-pha ...... data in neonates and children.
@en
type
label
Population pharmacokinetic-pha ...... data in neonates and children.
@ast
Population pharmacokinetic-pha ...... data in neonates and children.
@en
prefLabel
Population pharmacokinetic-pha ...... data in neonates and children.
@ast
Population pharmacokinetic-pha ...... data in neonates and children.
@en
P2093
P1476
Population pharmacokinetic-pha ...... data in neonates and children.
@en
P2093
Hiroki Ohge
Kayo Ikeda
Kazuro Ikawa
Kenichi Yoshizawa
Norifumi Morikawa
P304
P356
10.1097/INF.0B013E31829B5880
P577
2013-11-01T00:00:00Z